# Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

> **NCT00665782** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 24 (actual)

## Conditions studied

- Anxiety Disorder
- Breast Cancer
- Depression
- Psychosocial Effects of Cancer and Its Treatment

## Interventions

- **OTHER:** laboratory biomarker analysis
- **OTHER:** questionnaire administration
- **OTHER:** study of socioeconomic and demographic variables
- **PROCEDURE:** assessment of therapy complications
- **PROCEDURE:** psychosocial assessment and care
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT00665782
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665782, "Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00665782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*